A prospective cohort study measuring cost-benefit analysis of the Otago Exercise Programme in community dwelling adults with rheumatoid arthritis

BMC Health Services Research
Siyar AbdulrazaqEmma K Stanmore

Abstract

Falls are one of the major health problems in adults with Rheumatoid Arthritis (RA). Interventions, such as the Otago Exercise Programme (OEP), can reduce falls in community dwelling adults by up to 35%. The cost-benefits of such a programme in adults with RA have not been studied. The aims of this study were to determine the healthcare cost of falls in adults with RA, and estimate whether it may be cost efficient to roll out the OEP to improve function and prevent falls in adults living with RA. Patients with Rheumatoid Arthritis aged ≥18 years were recruited from four rheumatology clinics across the Northwest of England. Participants were followed up for 1 year with monthly fall calendars, telephone calls and self-report questionnaires. Estimated medical cost of a fall-related injury incurred per-person were calculated and compared with OEP implementation costs to establish potential economic benefits. Five hundred thirty-five patients were recruited and 598 falls were reported by 195 patients. Cumulative medical costs resulting from all injury leading to hospital services is £374,354 (US$540,485). Average estimated cost per fall is £1120 (US$1617). Estimated cost of implementing the OEP for 535 people is £116,479 (US$168,504...Continue Reading

References

Jan 1, 1995·Annals of the Rheumatic Diseases·C CooperM Mitchell
Aug 1, 1997·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·K D Fessel, M C Nevitt
Apr 17, 2001·Annals of the Rheumatic Diseases·T M HuuskoR Sulkava
May 25, 2002·Journal of the American Geriatrics Society·M Clare RobertsonNancy Devlin
Aug 23, 2003·Journal of Epidemiology and Community Health·P ScuffhamR Legood
Oct 15, 2003·Arthritis and Rheumatism·Marian JamisonPeggy A Miller
Dec 15, 2004·Australian Health Review : a Publication of the Australian Hospital Association·Delia HendrieMatthew Legge
Apr 9, 2005·Annals of the Rheumatic Diseases·C ArmstrongT W O'Neill
Sep 3, 2005·Journal of the American Geriatrics Society·Sarah E LambUNKNOWN Prevention of Falls Network Europe and Outcomes Consensus Group
Oct 5, 2006·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·J A StevensT R Miller
Jun 16, 2007·Lancet·Josef S SmolenPaul Emery
Apr 17, 2008·Journal of Epidemiology and Community Health·K C HeeschW J Brown
Jan 23, 2009·Food & Nutrition Research·Magnus K KarlssonCaroline Karlsson
Jul 21, 2009·Clinical Rheumatology·Takefumi FuruyaHisashi Yamanaka
Oct 14, 2009·Annals of the Rheumatic Diseases·E SmuldersW Van Lankveld
Feb 2, 2010·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M HayashibaraR Teshima
Oct 12, 2010·Clinics in Geriatric Medicine·Vicky ScottLori Wagar
Mar 16, 2011·Canadian Journal on Aging = La Revue Canadienne Du Vieillissement·Nancye May Peel
Nov 10, 2012·Arthritis Care & Research·Emma K StanmoreChris Todd
Feb 26, 2013·Arthritis Care & Research·Emma K StanmoreChris Todd
May 23, 2013·Nursing & Health Sciences·Chutima MeechamnanBarbara Burns McGrath
Feb 20, 2014·Annals of the Rheumatic Diseases·Marita CrossLyn March
Feb 11, 2015·Journal of Safety Research·Vilma Carande-KulisIleana Arias
Sep 12, 2015·Perspectives in Public Health·W J Bryans

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.